Correlation Between Metabolic Syndrome and Hyperuricemia: A Systematic Review and Meta-analysis
American Journal of Hypertension · 2025
DOI: 10.1093/ajh/hpaf031 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Jihuan Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Teaching and Research, Jilin Province FAW General Hospital, Changchun, China. Hauptthemen laut MEDLINE: Hyperuricemia, Metabolic Syndrome, Uric Acid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Health Technology Capacity Improvement Project, Health Commission of Jilin Province.
Abstract (Originalsprache)
BACKGROUND The main goal of this study was to conduct a meta-analysis and systematic review to examine the correlation between metabolic syndrome (MetS) and hyperuricemia. METHODS All studies available in PubMed, Cochrane Library, Embase, and Web of Science were obtained within the retrieval timeframe ending on 9 December 2023. Utilizing the Agency for Healthcare Research and Quality (AHRQ) and the Newcastle-Ottawa Scale (NOS), the included studies underwent quality appraisal, and Stata v14 software was employed for the subsequent data analysis. RESULTS A total of 40 studies, covering 214,091 patients, were selected based on specified inclusion and exclusion criteria. The analysis revealed a substantial association between MetS and hyperuricemia (odds ratio (OR) = 2.25, 95% confidence interval (CI) 1.19–4.26, P < 0.001). The metabolically abnormal overweight/obese group (MUHOWO) exhibited a heightened risk of hyperuricemia (OR = 3.54, 95% CI 2.66–4.71, P = 0.002). Additionally, hyperuricemia increased the likelihood of developing MetS (OR = 2.13, 95% CI 1.63–2.79, P < 0.001). Stratified by gender, hyperuricemia elevated the risk of MetS in both men (OR = 1.92, 95% CI 1.43–2.58, P < 0.001) and women (OR = 2.13, 95% CI 1.62–2.8, P < 0.001). CONCLUSIONS This meta-analysis and systematic review robustly affirm a significant bidirectional association between MetS and hyperuricemia. The increased risk observed, especially in MUHOWO and across gender lines, underscores the clinical relevance. Addressing MetS emerges as crucial in preventing and managing hyperuricemia, and vice versa. These findings offer valuable insights, urging further research into underlying mechanisms for more targeted interventions and personalized treatments in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Teaching and Research, Jilin Province FAW General Hospital, Changchun, China.
- Department of Health Checkup & Primary Care, Jilin Province FAW General Hospital, Changchun, China.
- Department of Organization and Personnel, Jilin Province FAW General Hospital, Changchun, China.
- Department of Magnetic Resonance, Jilin Province FAW General Hospital, Changchun, China.
- Hospital Director's Office, Jilin Province FAW General Hospital, Changchun, China.
Förderung
- Health Technology Capacity Improvement Project
- Health Commission of Jilin Province
Zitieren
APA
Fan, J., Bian, C., Wang, J., Wang, X., Cheng, Y., & Lei, J. (2025). Correlation Between Metabolic Syndrome and Hyperuricemia: A Systematic Review and Meta-analysis. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf031
Vancouver
Fan J, Bian C, Wang J, Wang X, Cheng Y, Lei J. Correlation Between Metabolic Syndrome and Hyperuricemia: A Systematic Review and Meta-analysis. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf031
BibTeX
@article{Fan2025,
author = {Fan, Jihuan and Bian, Cuicui and Wang, Jiapeng and Wang, Xinyue and Cheng, Yanhua and Lei, Jie},
title = {Correlation Between Metabolic Syndrome and Hyperuricemia: A Systematic Review and Meta-analysis},
journal = {American Journal of Hypertension},
year = {2025},
doi = {10.1093/ajh/hpaf031}
}
EUVIMED